UY27841A1 - Amidas de ácidos 2-heteroarilcarboxílicos - Google Patents

Amidas de ácidos 2-heteroarilcarboxílicos

Info

Publication number
UY27841A1
UY27841A1 UY27841A UY27841A UY27841A1 UY 27841 A1 UY27841 A1 UY 27841A1 UY 27841 A UY27841 A UY 27841A UY 27841 A UY27841 A UY 27841A UY 27841 A1 UY27841 A1 UY 27841A1
Authority
UY
Uruguay
Prior art keywords
heteroarilcarboxílicos
amides
acids
prophylaxis
learning
Prior art date
Application number
UY27841A
Other languages
English (en)
Inventor
Dr Joachim Luithle
Dr Frank-Gerhard Bnb
Dr Christina Erb
Dr Frank-Thorsten Hafner
Dr Katrin Schnizler
Dr Timo Flebner
Dr Marja Van Kampen
Dr Franz Josef Van Der Staay
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10257078A external-priority patent/DE10257078A1/de
Priority claimed from DE2002157537 external-priority patent/DE10257537A1/de
Priority claimed from DE10305922A external-priority patent/DE10305922A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of UY27841A1 publication Critical patent/UY27841A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

La invención trata de nuevas amidas de ácidos 2-heteroarilcarboxílicos y de su uso para la preparación de medicamentos para el tratamiento y/o la profilaxis de enfermedades y para mejorar la capacidad perceptiva, la capacidad de concentración, la capacidad de aprendizaje y/o la capacidad de memoria.
UY27841A 2002-06-10 2003-06-10 Amidas de ácidos 2-heteroarilcarboxílicos UY27841A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10225536 2002-06-10
DE10257078A DE10257078A1 (de) 2002-12-06 2002-12-06 2-Heteroarylcarbonsäureamide
DE2002157537 DE10257537A1 (de) 2002-12-10 2002-12-10 2-Heteroarylcarbonsäureamide
DE10305922A DE10305922A1 (de) 2002-06-10 2003-02-13 2-Heteroarylcarbonsäureamide

Publications (1)

Publication Number Publication Date
UY27841A1 true UY27841A1 (es) 2003-12-31

Family

ID=29740887

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27841A UY27841A1 (es) 2002-06-10 2003-06-10 Amidas de ácidos 2-heteroarilcarboxílicos

Country Status (16)

Country Link
US (5) US7977485B2 (es)
EP (1) EP1515967B1 (es)
JP (1) JP4542891B2 (es)
CN (1) CN1675204A (es)
AT (1) ATE344262T1 (es)
AU (1) AU2003238450A1 (es)
BR (1) BR0312446A (es)
CA (1) CA2488761C (es)
DE (1) DE50305587D1 (es)
ES (1) ES2276072T3 (es)
IL (1) IL165505A0 (es)
MX (1) MXPA04012439A (es)
NO (1) NO20050063L (es)
PL (1) PL374551A1 (es)
UY (1) UY27841A1 (es)
WO (1) WO2003104227A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
WO2003104227A1 (de) * 2002-01-20 2003-12-18 Bayer Healthcare Ag 2-heteroarylcarbonsäureamide
ES2405594T3 (es) * 2002-09-25 2013-05-31 Memory Pharmaceuticals Corporation Idazoles, benzotiazoles y benzisotiazoles, y preparación y usos de los mismos
DE602004031124D1 (de) 2003-08-13 2011-03-03 Neurosearch As Neue chinuklidinderivative und deren pharmazeutische verwendung
DE602004010299T2 (de) 2003-12-22 2008-09-18 Memory Pharmaceuticals Corp. Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen
MXPA06010852A (es) * 2004-03-25 2007-01-16 Memory Pharm Corp Indazoles, benzotiazoles, benzoisotiazoles, bencisoxazoles y preparacion y usos de los mismos.
US7514450B2 (en) 2004-05-19 2009-04-07 Neurosearch A/S Azabicyclic aryl derivatives
CN100588657C (zh) * 2004-10-15 2010-02-10 神经研究公司 新的氮杂双环芳基衍生物及其医药用途
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
BRPI0821689A2 (pt) * 2007-12-26 2015-06-16 Eisai R&D Man Co Ltd Processo para a produção de derivados de piridina substituídos por heterociclo
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
SI3029039T1 (en) 2010-05-17 2018-04-30 Forum Pharmaceuticals Inc. Pharmaceutical formulations containing crystalline forms of (R) -7-chloro-N- (quinuclidin-3-yl) benzo (b) thiophene-2-carboxamide hydrochloride monohydrate
CN103380129B (zh) 2010-12-20 2016-04-20 阿克图拉姆生命科学股份公司 2-甲酰胺-4-哌嗪基-苯并呋喃衍生物
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法
WO2022060764A1 (en) * 2020-09-18 2022-03-24 Merck Sharp & Dohme Corp. Modified benzofuran-carboxamides as glucosylceramide synthase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
WO2003029252A1 (en) * 2001-10-02 2003-04-10 Pharmacia & Upjohn Company Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
WO2003104227A1 (de) * 2002-01-20 2003-12-18 Bayer Healthcare Ag 2-heteroarylcarbonsäureamide
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe

Also Published As

Publication number Publication date
US20120258964A1 (en) 2012-10-11
PL374551A1 (en) 2005-10-31
ATE344262T1 (de) 2006-11-15
BR0312446A (pt) 2005-04-19
EP1515967B1 (de) 2006-11-02
NO20050063L (no) 2005-01-06
IL165505A0 (en) 2006-01-15
US20160122337A1 (en) 2016-05-05
JP4542891B2 (ja) 2010-09-15
US20140350008A1 (en) 2014-11-27
CA2488761C (en) 2011-05-31
WO2003104227A1 (de) 2003-12-18
MXPA04012439A (es) 2005-04-19
EP1515967A1 (de) 2005-03-23
CA2488761A1 (en) 2003-12-18
US7977485B2 (en) 2011-07-12
US20060160877A1 (en) 2006-07-20
DE50305587D1 (en) 2006-12-14
AU2003238450A1 (en) 2003-12-22
US20110263591A1 (en) 2011-10-27
US10214524B2 (en) 2019-02-26
CN1675204A (zh) 2005-09-28
JP2005533052A (ja) 2005-11-04
US9067931B2 (en) 2015-06-30
ES2276072T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
NO20050063L (no) 2-heteroaryl karboksamider
NL300933I2 (nl) Letermovir
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
CY1110019T1 (el) Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες
NO20050210L (no) Antibakterielle amid-makrocykluser
ATE408601T1 (de) Fredericamycin-derivate
ATE441417T1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
ATE374196T1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
ATE453642T1 (de) Substituierte phenylaminopyrimidine
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
NO20055741L (no) Nye kjemiske forbindelser
WO2003078430A8 (de) Essig- und propionsäureamide
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
ATE446285T1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE395602T1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
DE502004012196D1 (de) Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen
MY148252A (en) 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
ATE359270T1 (de) Phenyl-piperidin-4-yliden-methyl-benzamidderiva e zur behandlung von schmerz oder magen-darm- erkrankungen
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
DE60219495D1 (de) Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten
DE502006004735D1 (de) Mittel zur behandlung von infektionen

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150525